Shih-Han Kao

Title: Innovations by Shih-Han Kao in Medical Science

Introduction

Shih-Han Kao is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical science, particularly in the area of anti-bacterial treatments and leukemia therapies. His innovative work has led to the development of a unique composition aimed at combating serious health issues.

Latest Patents

Shih-Han Kao holds a patent for an "Anti-bacterial infection, inflammation, and leukemia composition and use thereof." This patent describes a method of inhibiting the growth of Gram-positive bacteria by administering an effective amount of Tellimagrandin II, along with its pharmaceutically acceptable salt, enantiomer, isomer, or tautomer. The method specifically targets methicillin-resistant bacteria. Additionally, it outlines a treatment for sepsis and leukemia using the same compound, showcasing its versatility and potential impact on public health.

Career Highlights

Kao is affiliated with Kaohsiung Medical University, where he continues to engage in research and development. His work is characterized by a commitment to addressing critical health challenges through innovative solutions. With a focus on practical applications, he aims to improve patient outcomes in various medical conditions.

Collaborations

Shih-Han Kao collaborates with esteemed colleagues, including Lih-Geeng Chen and Yen-Hsu Chen. These partnerships enhance the research efforts and contribute to the advancement of medical science.

Conclusion

Shih-Han Kao's contributions to medical innovation, particularly through his patent on anti-bacterial and leukemia treatments, highlight his role as a significant figure in the field. His work at Kaohsiung Medical University and collaborations with fellow researchers further emphasize the importance of teamwork in advancing healthcare solutions.